Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines.
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Abstract
The International Mouse Phenotyping Consortium (IMPC) systematically produces and phenotypes mouse lines with presumptive null mutations to provide insight into gene function. The IMPC now uses the programmable RNA-guided nuclease Cas9 for its increased capacity and flexibility to efficiently generate null alleles in the C57BL/6N strain. In addition to being a valuable novel and accessible research resource, the production of 3313 knockout mouse lines using comparable protocols provides a rich dataset to analyze experimental and biological variables affecting in vivo gene engineering with Cas9. Mouse line production has two critical steps - generation of founders with the desired allele and germline transmission (GLT) of that allele from founders to offspring. A systematic evaluation of the variables impacting success rates identified gene essentiality as the primary factor influencing successful production of null alleles. Collectively, our findings provide best practice recommendations for using Cas9 to generate alleles in mouse essential genes, many of which are orthologs of genes linked to human disease.
Description
Acknowledgements: We thank all technical personnel at the IMPC production centres for their contributions. H.E., E.A., M.G., L.L., C.M., and L.M.J.N. were supported by Ontario Genomics and Genome Canada OGI-051, OGI-090, OGI-137 and the Canada Foundation for Innovation. M-C.B. and Y.H. were supported by the Université de Strasbourg, the CNRS, the INSERM and the ‘Investissements d’avenir’ programs (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT and ANR-10-INBS-07 PHENOMIN). A.C., G.C., M.M., L.T., and S.W. were supported by the Medical Research Council MC_UP_1502/3 International Mouse Phenotyping Consortium—building a functional catalogue of a mammalian genome. B.D., G.D., E.R., H.W.-J., D.A., A.B., R.R.-S., and W.S. were supported by the Wellcome Trust. P.M. and H.P. were supported by European Molecular Biology Laboratory core funding. P.K. and R.S. used services of the Czech Centre for Phenogenomics supported by the Czech Academy of Sciences RVO 68378050 and project LM2018126 Czech Centre for Phenogenomics provided by Ministry of Education, Youth and Sports of the Czech Republic, LM2015040 Czech Centre for Phenogenomics by MEYS, CZ.1.05/2.1.00/19.0395 Higher quality and capacity for transgenic models by MEYS and ERDF, CZ.1.05/1.1.00/02.0109 Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University in Vestec (BIOCEV) by MEYS and ERDF, CZ.02.1.01/0.0/0.0/16_013/0001789 Upgrade of the Czech Centre for Phenogenomics by MEYS and ESIF. Research reported in this publication was supported by the NIH Common Fund, the Office of The Director and the National Human Genomic Research Institute of the National Institutes of Health (U42OD011174 and UMIHG006348 supported A.C., D.L., G.C., F.D., I.L., M.M., J.S., L.T., S.W., M.D., and J.D.H.; U42OD011175 and UM1OD023221 supported M.G., L.L., C.M., L.M.J.N., B.W., J.A.W., M.R., and K.L.; U42OD011185 and UM1OD023222 supported L.G., K.P., R.B., J.K.W., and S.A.M.; UM1HG006370 supported A.-M.M. and H.P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funder: Wellcome Trust; doi: http://dx.doi.org/10.13039/100010269
Journal Title
Conference Name
Journal ISSN
2045-2322
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
Genome Canada (OGI-051, OGI-090, OGI-137)
National Institutes of Health (U42OD011185, UM1OD023222, U42OD011175, UM1OD023221, U42OD011174, UMIHG006348, UM1HG006370)
Medical Research Council (MC_UP_1502/3)
Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences (RVO 68378050)
Ministry of Education, Youth and Sports of the Czech Republic (LM2018126)
Institut National de la Santé et de la Recherche Médicale (ANR-10-IDEX-0002-02, ANR-10-LABX-0030-INRT, ANR-10-INBS-07)

